ARTICLE | Company News
Alliant, Tyco sales and marketing update
June 7, 2004 7:00 AM UTC
TYC's subsidiary Mallinckrodt Inc. (St. Louis, Mo.) granted Alliant exclusive U.S. marketing rights to two undisclosed compounds to treat attention deficit hyperactivity disorder (ADHD). ...